Stock Fundamentals

Company Information

Company Name
Marinus Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US56854Q1013
CIK: 0001267813
CUSIP: 56854Q101
Currency: USD
Full Time Employees: 165
Phone: 484 801 4670
Fiscal Year End: December
IPO Date: Jul 31, 2014
Description:

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY (ganaxolone), an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, and tuberous sclerosis complex. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation and Tenacia Biotechnology (Shanghai) Co., Ltd. Marinus Pharmaceuticals, Inc. was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.

Address:

5 Radnor Corporate Center, Radnor, PA, United States, 19087

Directors & Officers

Name Title Year Born
Dr. Scott N. Braunstein M.D. CEO, President & Chairman 1963
Mr. Steven E. Pfanstiel C.M.A., M.B.A. COO, CFO & Treasurer 1973
Dr. Joseph Hulihan M.D. Chief Medical Officer 1957
Dr. Alex Aimetti Ph.D. Chief Scientific Officer NA
Ms. Sonya Weigle Senior VP of Investor Relations, Human Resources & Corporate Affairs NA
Ms. Martha E. Manning Esq., J. D. Senior VP, General Counsel & Secretary 1955
Molly Cameron Director of Corporate Communications & Investor Relations NA
Dr. Kimberly A. McCormick Pharm.D. Chief Regulatory & Quality Assurance Officer NA
Ms. Christina Shafer Chief Commercial Officer 1977
Mr. David Czekai Chief Chemistry, Manufacturing & Controls Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 21, 2025 Elan Ezickson N/A Sale 1.60K $0.54 $864.00
Aug 14, 2024 Scott Braunstein N/A Purchase 5.93K $1.10 $6.53K
Aug 05, 2024 Christina Shafer N/A Sale 3.82K $1.14 $4.35K
Aug 05, 2024 Martha E Manning N/A Sale 3.62K $1.13 $4.09K
Aug 05, 2024 Scott Braunstein N/A Sale 12.15K $1.13 $13.72K
Aug 05, 2024 Steven Pfanstiel N/A Sale 4.66K $1.13 $5.26K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Beryl Capital Management LLC 4.23M Dec 31, 2024 7.66% $0.51 0.00%
Morgan Stanley - Brokerage Accounts 3.30M Dec 31, 2024 5.97% $0.00 1,898.71%
ODDO BHF Asset Management SAS 2.70M Dec 31, 2024 4.89% $0.07 0.00%
Bain Capital Life Sciences Investors, LLC 2.69M Dec 31, 2024 4.88% $0.17 0.00%
Aberdeen Group PLC 2.66M Dec 31, 2024 4.81% $0.00 0.00%
Vanguard Group Inc 2.60M Dec 31, 2024 4.70% $0.00 -7.36%
Woodline Partners LP 2.34M Dec 31, 2024 4.23% $0.01 84.75%
GSA Capital Partners LLP 1.84M Dec 31, 2024 3.33% $0.07 80.74%
TANG CAPITAL MANAGEMENT LLC 1.64M Dec 31, 2024 2.97% $0.06 -65.07%
BlackRock Inc 883.68K Dec 31, 2024 1.60% $0.00 -52.47%
Geode Capital Management, LLC 529.05K Dec 31, 2024 0.96% $0.00 -6.94%
Citadel Advisors Llc 501.91K Dec 31, 2024 0.91% $0.00 108.78%
JPMorgan Chase & Co 487.58K Dec 31, 2024 0.88% $0.00 83.04%
Prudential Investment Management Inc 385.25K Sep 30, 2024 0.70% $0.00 0.00%
Schroder Investment Management Group 290.00K Dec 31, 2024 0.53% $0.00 0.00%
UBS Group AG 258.94K Dec 31, 2024 0.47% $0.00 11,367.85%
Royal Bank of Canada 249.14K Dec 31, 2024 0.45% $0.00 303.42%
Millennium Management LLC 239.41K Dec 31, 2024 0.43% $0.00 -50.38%
State Street Corp 222.58K Dec 31, 2024 0.40% $0.00 7.80%
XTX Topco Ltd 219.82K Dec 31, 2024 0.40% $0.01 1,564.66%

Shares Statistics

Shares Outstanding: 55.22M
Shares Float: 37.39M
% Insiders: 1,094.30%
% Institutions: 8,303.70%
Short % Float: 10.32%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 NT Ext Equity Mkt Idx Fd - NL 54.12K 0.10% ▲ 0.00% Dec 31, 2024
2 Northern Trust Extended Eq Market Idx 48.88K 0.09% ▲ 0.00% Dec 31, 2024
3 NT Ext Equity Mkt Idx Fd - L 48.88K 0.09% ▲ 0.00% Dec 31, 2024
4 T. Rowe Price U.S. Equities Tr 44.20K 0.08% ▲ 0.00% Dec 31, 2024
5 NT Ext Equity Mkt Idx Fd - DC - NL - T2 42.89K 0.08% ▼ 1.63% Dec 31, 2024
6 U.S. Equity Market Fund F 13.13K 0.02% ▼ 0.05% Dec 31, 2024
7 NT Ext Eq Mkt Indx Fd DC Lend T4 11.65K 0.02% ▲ 0.00% Dec 31, 2024
8 NT Ext Eq Mkt Indx Fd DC Lend T3 11.65K 0.02% ▲ 0.00% Dec 31, 2024
9 NT Ext Eq Mkt Indx Fd DC Lending Tier 5 11.65K 0.02% ▲ 54.42% Dec 31, 2024
10 1290 VT Micro Cap K 10.86K 0.02% ▲ 0.00% Jan 31, 2025

Valuation Metrics

Enterprise Value: $44.18M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $30.37M
EBITDA: $-128.66M
PEG Ratio: $0.00
Book Value: $0.31
Earnings/Share: $-2.47
Profit Margin: 0.00%
Operating Margin: -375.94%
ROA (TTM): -57.75%
ROE (TTM): -2,986.55%
Revenue (TTM): $30.26M
Revenue/Share (TTM): $0.54
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 32.50%

Stock Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2023-12-31 4.07x 4.53x 0.90x -7.78x -0.61x
2022-12-31 4.38x 0.63x 0.55x -10.57x -14.29x
2021-12-31 3.03x 0.77x 0.61x -37.54x -0.43x
2020-12-31 13.06x 0.00x 0.09x -136.15x -0.01x
2019-12-31 11.72x 0.01x 0.11x N/A -0.01x
2018-12-31 10.70x 0.00x 0.09x N/A 0.00x
2017-12-31 13.18x 0.00x 0.04x -119.77x 0.00x
2016-12-31 3.75x 0.24x 0.32x -60.87x -0.19x
2015-12-31 7.77x 0.16x 0.21x -51.44x -0.30x
2014-12-31 24.59x 0.34x 0.18x -101.88x -1.31x
2013-12-31 4.99x 0.00x 0.20x -59.36x 0.00x
2012-12-31 1.93x 0.64x 0.52x -4.46x -2.50x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about MRNS.US!